Chlorhexidine decontamination of sputum for culturing Mycobacterium tuberculosis

BMC Microbiology

Michel Drancourt²  Shady Asmar¹ 

[1]Aix Marseille Université, URMITE, UM63, CNRS 7278, IRD 198, Inserm 1095, Institut Hospitalo-Universitaire «Méditerranée Infection», AP-HM, Marseille, 13005, France

[2]Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, 27, Boulevard Jean Moulin, Marseille, 13385, Cedex 5, France

关键词: Standards for Reporting of Diagnostic Accuracy (STARD);    Sensitivity;    Contamination;    Culture;    N-acetyl-cysteine-sodium chloride;    Squalamine;    Chlorhexidine;    Decontamination;    Mycobacterium tuberculosis;   

Others  :  1227605
DOI  :  10.1186/s12866-015-0479-4

 received in 2015-05-06, accepted in 2015-07-07,  发布年份 2015

【 摘 要 】

Background

Culture of Mycobacterium tuberculosis is the gold standard method for the laboratory diagnosis of pulmonary tuberculosis, after effective decontamination.

Results

We evaluated squalamine and chlorhexidine to decontaminate sputum specimens for the culture of mycobacteria. Eight sputum specimens were artificially infected with 10 ⁵colony-forming units (cfu)/mL Mycobacterium tuberculosis and Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans as contaminants. In the second step, we tested chlorhexidine-based decontamination on 191 clinical specimens, (Chlorhexidine, 0.1, 0.5 and 0.7 %). In a last step, growth of contaminants and mycobacteria was measured in 75 consecutive sputum specimens using the routine NALC-NaOH decontamination protocol or with 0.7 % chlorhexidine decontamination and an inoculation on Coletsos medium.

In the artificially model, contaminants grew in 100 % of the artificially infected sputum specimens decontaminated using 100 mg/mL squalamine, in 62.5 % of specimens decontaminated using N-Acetyl-L-Cysteine-Sodium Hydroxide (NALC-NaOH), and in 0 % of specimens decontaminated using 0.1 %, 0.35 %, or 1 % chlorhexidine (P < 0.05). These specimens yielded <10 ²  cfu M. tuberculosis using NALC-NaOH and > 1.4.10 ²  cfu M. tuberculosis when any concentration of chlorhexidine was used (P < 0.05).

In the second step we found that 0.7 %-chlorhexidine yielded 0 % contamination rate, 3.2 % for 0.5 %-chlorhexidine and 28.3 % for 0.1 %-chlorhexidine. As for the 75 specimens treated in parallel by both methods we found that when using the standard NALC-NaOH decontamination method, 8/75 (10.7 %) specimens yielded M. tuberculosis colonies with a time to detection of 17.5 ± 3 days and an 8 % contamination rate. Additionally, 14 specimens yielded mycobacteria colonies (12 M. tuberculosis, and 2 Mycobacterium bolletii) (18.7 %) (P = 0.25), which has yielded a 100 % sensitivity for the chlorhexidine protocol. Time to detection was of 15.86 ± 4.7 days (P = 0.39) and a 0 % contamination rate (P < 0.05) using the 0.7 %-chlorhexidine protocol.

Conclusion

In our work we showed for the first time that chlorhexidine based decontamination is superior to the standard NALC-NaOH method in the isolation of M. tuberculosis from sputum specimens. We currently use 0.7 %-chlorhexidine for the routine decontamination of sputum specimens for the isolation of M. tuberculosis and non-tuberculosis mycobacteria on egg-lecithin containing media.

【 授权许可】

   
2015 Asmar and Drancourt.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Alli OA, Ogbolu OD, Alaka OO. Direct molecular detection of Mycobacterium tuberculosis complex from clinical samples - An adjunct to cultural method of laboratory diagnosis of tuberculosis. N Am J Med Sci. 2011; 3:281-8.
• [2]Tiruviluamala P, Reichman LB. Tuberculosis. Annu Rev Public Health. 2002; 23:403-26.
• [3]Burdz TV, Wolfe J, Kabani A. Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry. Diagn Microbiol Infect Dis. 2003; 47:503-9.
• [4]El Khéchine A, Henry M, Raoult D, Drancourt M. Detection of Mycobacterium tuberculosis complex organisms in the stools of patients with pulmonary tuberculosis. Microbiology. 2009; 155:2384-9.
• [5]Kumar V, Balaji S, Gomathi NS, Venkatesan P, Sekar G et al.. Phage cocktail to control the exponential growth of normal flora in processed sputum specimens grown overnight in liquid medium for rapid TB diagnosis. J Microbiol Methods. 2006; 68:536-42.
• [6]Kassaza K, Orikiriza P, Llosa A, Bazira J, Nyehangane D et al.. Lowenstein-Jensen selective medium for reducing contamination in Mycobacterium tuberculosis culture. J Clin Microbiol. 2014; 52:2671-3.
• [7]Coulter P. Specimen Digestion, Decontamination for Mycobacteriology Culture Guidelines. 2009; Pro67-C-15-G.
• [8]Petroff SA. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med. 1915; 21:38-42.
• [9]Kubica GP, Dye WE, Cohn ML, Middlebrook G. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis. 1963; 87:775-9.
• [10]Swai HF, Mugusi FM, Mbwambo KJ. Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm. BMC Res Notes. 2011; 1:475. BioMed Central Full Text
• [11]Peres PJ, Gevaudan MJ, Gulian PC, de Micco P. Une méthode de traitement des produits pathologiques en vue de l’isolement des mycobactéries. Revue Fr Lab. 1988; 173:67-74.
• [12]De Bel A, De Geyter D, De Schutter I, Mouton C, Wellemans I et al.. Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients. J Clin Microbiol. 2013; 51:4204-6.
• [13]Ferroni A, Vu-Thien H, Lanotte P, Le Bourgeois M, Sermet-Gaudelus I et al.. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J Clin Microbiol. 2006; 44:2237-9.
• [14]Moore KS, Wehrli S, Roder H, Rogers M, Forrest JN et al.. Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci U S A. 1993; 15(90):1354-8.
• [15]Ghodbane R, Ameen SM, Drancourt M, Brunel JM. In vitro antimicrobial activity of squalamine derivatives against mycobacteria. Tuberculosis (Edinb). 2013; 93:565-6.
• [16]Salmi C, Loncle C, Vidal N, Letourneux Y, Fantini J et al.. Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One. 2008; 23(3): Article ID e2765
• [17]Ghodbane R, Raoult D, Drancourt M. Dramatic reduction of culture time of Mycobacterium tuberculosis. Sci Rep. 2014; 4:4236.
• [18]Seng P, Drancourt M, Gouriet F, Lascola B, Fournier PE et al.. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009; 49:543-51.
• [19]Drancourt M, Berger P, Raoult D. Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol. 2004; 42:2197-202.
• [20]Diagnostic standards and classification of tuberculosis in adults children, 2000. Am J Respir Crit Care Med. 2000; 161:1376-95.
• [21]Mukesh S, Rabindra NM, Nageswari RG, Savita VJ, Kalpana A, Vivian W. Comparison of modified Petroff’s and N-acetyl-L-cysteine-sodium hydroxide methods for sputum decontamination in tertiary care hospital in India. Tuberculosis (Edinb.). 2012; 93:565-6.
• [22]Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis. 2003; 7:569-74.
• [23]Samra Z, Kaufman L, Bechor J, Bahar J. Comparative study of three culture systems for optimal recovery of mycobacteria from different clinical specimens. Eur J Clin Microbiol Infect Dis. 2000; 19:750-4.
• [24]Saiman L, Siegel JD, LiPuma JJ, Brown RF, Bryson EA et al.. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014; 35 Suppl 1:S1-S67.